Inhibitory effect of Duabanga grandiflora on MRSA biofilm formation via prevention of cell-surface attachment and PBP2a production

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Carolina SantiagoKang Nee Ting

Abstract

Formation of biofilms is a major factor for nosocomial infections associated with methicillin-resistance Staphylococcus aureus (MRSA). This study was carried out to determine the ability of a fraction, F-10, derived from the plant Duabanga grandiflora to inhibit MRSA biofilm formation. Inhibition of biofilm production and microtiter attachment assays were employed to study the anti-biofilm activity of F-10, while latex agglutination test was performed to study the influence of F-10 on penicillin-binding protein 2a (PBP2a) level in MRSA biofilm. PBP2a is a protein that confers resistance to beta-lactam antibiotics. The results showed that, F-10 at minimum inhibitory concentration (MIC, 0.75 mg/mL) inhibited biofilm production by 66.10%; inhibited cell-surface attachment by more than 95%; and a reduced PBP2a level in the MRSA biofilm was observed. Although ampicilin was more effective in inhibiting biofilm production (MIC of 0.05 mg/mL, 84.49%) compared to F-10, the antibiotic was less effective in preventing cell-surface attachment. A higher level of PBP2a was detected in ampicillin-treated MRSA showing the development of further resistance in these colonies. This study has shown that F-10 possesses anti-biofilm activity, which ...Continue Reading

References

May 21, 1999·Science·J W CostertonE P Greenberg
Feb 5, 2000·The Journal of Hospital Infection·D Mack
Oct 6, 2000·Annual Review of Microbiology·G O'TooleR Kolter
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·D F Brown
Apr 16, 2002·Molecular Microbiology·Friedrich Götz
Aug 22, 2002·Archives of Microbiology·Brigitte Berger-Bächi, Susanne Rohrer
Apr 23, 2005·Journal of Natural Products·Daniel R Zuidema, Paul B Jones
Jun 1, 2006·The American Journal of Medicine·Louis B Rice
Dec 2, 2006·Zeitschrift Für Naturforschung. C, a Journal of Biosciences·Berrin OzçelikGülnur Toker
Jun 1, 2007·Clinical Pharmacology and Therapeutics·J L del Pozo, R Patel
Jul 2, 2008·Infection and Immunity·Joerg OverhageRobert E W Hancock
Sep 19, 2009·Microbial Ecology·Meghan W Durham-ColleranMonique L van Hoek
Jan 30, 2010·Natural Product Reports·Muhammad SaleemAbdul Jabbar
Nov 26, 2010·Journal of Microbiological Methods·Mukhrizah OthmanKang Nee Ting
Apr 26, 2011·International Journal of Antimicrobial Agents·T P Tim Cushnie, Andrew J Lamb
Aug 16, 2011·Natural Product Research·Mukhrizah OthmanKang Nee Ting

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.